Genomic Testing Cooperative’s Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage

Genomic Testing Cooperative announced on Wednesday that the New York State Clinical Evaluation Program has approved its next-generation sequencing profiling tests for hematologic neoplasms and solid tumors.

The approved tests are the GTC Hematology Profile for 177 genes; GTC Hematology Fusion/Expression for 1,408 genes; GTC Hematology PLUS for 177 DNA and 1,408 RNA; GTC Liquid Biopsy, Hematology Profile for 177 genes; GTC Solid Tumor Profile for 434 genes; GTC Solid Tumor Profile Fusion/Expression for 1,408 genes; and GTC Solid Tumor PLUS for 434 DNA and 1,408 RNA.

Source: https://www.genomeweb.com/reimbursement-news/genomic-testing-cooperatives-hematologic-neoplasms-solid-tumor-tests-receive-ny